SA
VRNA

Shilanski & Associates’s Verona Pharma VRNA Stock Holding History

Shilanski & Associates’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$630K Sell
6,658
-35
-0.5% -$3.31K 0.18% 63
2025
Q1 		$425K Buy
6,693
+117
+2% +$7.43K 0.13% 67
2024
Q4 		$305K Buy
+6,576
New +$305K 0.1% 82